Episode Details
Back to Episodes
Novartis Expands U.S. Manufacturing with NC Facility
Description
Novartis unveils plans for a new manufacturing facility in Morrisville, North Carolina, as part of a $23 billion U.S. expansion. The 56,200 square foot site will produce active ingredients for solid dose tablets, capsules, and RNA therapies, bolstering their U.S. drug production capabilities. This addition brings their North Carolina facilities to five, solidifying their presence in the state and advancing their goal of domestic production for major U.S. medications.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/82ff11903857c768